- Home
- LTH vs SRRK Comparison
LTH vs SRRK Comparison
Compare LTH & SRRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LTH | SRRK |
|---|---|---|
| Founded | 1992 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Hotels/Resorts | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.5B | 4.6B |
| IPO Year | 2021 | 2018 |
Fundamental Metrics
Financial Performance| Metric | LTH | SRRK |
|---|---|---|
| Price | $25.56 | $45.31 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 9 |
| Target Price | $37.50 | ★ $47.00 |
| AVG Volume (30 Days) | 2.0M | ★ 2.1M |
| Earning Date | 11-04-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 88.46 | N/A |
| EPS | ★ 1.28 | N/A |
| Revenue | ★ $2,913,442,000.00 | N/A |
| Revenue This Year | $15.07 | N/A |
| Revenue Next Year | $10.88 | $20,271.77 |
| P/E Ratio | $19.93 | ★ N/A |
| Revenue Growth | ★ 15.77 | N/A |
| 52 Week Low | $21.49 | $22.71 |
| 52 Week High | $34.99 | $46.98 |
Technical Indicators
Market Signals| Indicator | LTH | SRRK |
|---|---|---|
| Relative Strength Index (RSI) | 45.04 | 70.32 |
| Support Level | $24.46 | $39.51 |
| Resistance Level | $27.11 | $43.94 |
| Average True Range (ATR) | 0.68 | 2.24 |
| MACD | 0.01 | 0.48 |
| Stochastic Oscillator | 32.48 | 89.42 |
Price Performance
Historical ComparisonAbout LTH Life Time Group Holdings Inc.
Life Time Group Holdings Inc is a lifestyle and leisure brand offering health, fitness, and wellness experiences to a community. It is engaged in designing, building, and operating distinctive and large, multi-use sports and athletic, professional fitness, family recreation, and spa centers in a resort-like environment, principally in residential locations of metropolitan areas in the United States and Canada.
About SRRK Scholar Rock Holding Corporation
Scholar Rock Holding Corp is a late-stage biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for treating serious diseases in which signaling by protein growth factors plays a fundamental role. Its pipeline includes Neuromuscular and Obesity, Immuno-oncology, Fibrotic Disease, and Hematology. The group operates and manages its business as a single segment to assess performance and make operating decisions.